On May 20, 2025, Needham analyst Mike Matson reiterated his "Buy" rating on Merit Medical Systems (MMSI, Financial). The analyst has maintained a price target of $108.00, unchanged from the prior target. This analysis continues to support the outlook for MMSI at a stable investment opportunity within the medical device sector.
The price target remains consistent with previous evaluations, reflecting no change in the estimated potential value of the stock. The reiteration of the "Buy" rating suggests confidence in the company's future performance and growth prospects. Investors continue to focus on Merit Medical Systems' consistent market positioning and strategic initiatives that align with the analyst's positive outlook.
